Consent and Public Engagement in an Era of Expanded Childhood Immunisation
Overview
Affiliations
Childhood immunisation programmes have seen well-heralded successes in disease control. An increasing number of scheduled vaccines, narrowing risk-benefit ratios and public attention to vaccine safety raise new questions about consent. We first explore the challenges that this highly dynamic environment poses for valid consent. Then, we broaden this discussion to wider public engagement by suggesting how the public - the bearers of vaccine risk and benefit - can be better involved in immunisation policy.
Anti-vaccination movements in the world and in Brazil.
Oliveira I, Cardoso L, Ferreira I, Alexandre-Silva G, Jacob B, Cerni F Rev Soc Bras Med Trop. 2022; 55:e05922021.
PMID: 35613224 PMC: 9131779. DOI: 10.1590/0037-8682-0592-2021.
Vaccine Hesitancy in Saudi Arabia: A Cross-Sectional Study.
Alaamri O, Okmi E, Suliman Y Trop Med Infect Dis. 2022; 7(4).
PMID: 35448835 PMC: 9025486. DOI: 10.3390/tropicalmed7040060.
McDonald C, Leask J, Chad N, Danchin M, Fethney J, Trevena L Vaccines (Basel). 2020; 8(3).
PMID: 32887503 PMC: 7565597. DOI: 10.3390/vaccines8030500.
The impact of rare but severe vaccine adverse events on behaviour-disease dynamics: a network model.
Bhattacharyya S, Vutha A, Bauch C Sci Rep. 2019; 9(1):7164.
PMID: 31073195 PMC: 6509123. DOI: 10.1038/s41598-019-43596-7.
Addressing vaccine hesitancy requires an ethically consistent health strategy.
Williamson L, Glaab H BMC Med Ethics. 2018; 19(1):84.
PMID: 30355355 PMC: 6201581. DOI: 10.1186/s12910-018-0322-1.